PL2137655T3 - Zdefiniowane produkty glikoproteinowe i powiązane sposoby - Google Patents

Zdefiniowane produkty glikoproteinowe i powiązane sposoby

Info

Publication number
PL2137655T3
PL2137655T3 PL08754908T PL08754908T PL2137655T3 PL 2137655 T3 PL2137655 T3 PL 2137655T3 PL 08754908 T PL08754908 T PL 08754908T PL 08754908 T PL08754908 T PL 08754908T PL 2137655 T3 PL2137655 T3 PL 2137655T3
Authority
PL
Poland
Prior art keywords
related methods
glycoprotein products
defined glycoprotein
products
methods
Prior art date
Application number
PL08754908T
Other languages
English (en)
Inventor
Ganesh Venkataraman
Brian Edward Collins
Carlos J Bosques
Lakshmanan Thiruneelakantapillai
Dorota A Bulik
Ian Christopher Parsons
Zachary Shriver
Rajeev Chillakuru
Original Assignee
Momenta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals Inc filed Critical Momenta Pharmaceuticals Inc
Publication of PL2137655T3 publication Critical patent/PL2137655T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Databases & Information Systems (AREA)
  • Biophysics (AREA)
  • Bioethics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL08754908T 2007-04-16 2008-04-15 Zdefiniowane produkty glikoproteinowe i powiązane sposoby PL2137655T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91210207P 2007-04-16 2007-04-16
PCT/US2008/060354 WO2008128227A1 (en) 2007-04-16 2008-04-15 Defined glycoprotein products and related methods
EP08754908A EP2137655B1 (en) 2007-04-16 2008-04-15 Defined glycoprotein products and related methods

Publications (1)

Publication Number Publication Date
PL2137655T3 true PL2137655T3 (pl) 2012-12-31

Family

ID=39553226

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08754908T PL2137655T3 (pl) 2007-04-16 2008-04-15 Zdefiniowane produkty glikoproteinowe i powiązane sposoby

Country Status (12)

Country Link
US (2) US20100113294A1 (pl)
EP (2) EP2528002B1 (pl)
JP (1) JP2010524467A (pl)
CN (1) CN101681396A (pl)
AU (1) AU2008240080A1 (pl)
BR (1) BRPI0810471A2 (pl)
CA (1) CA2682738A1 (pl)
ES (1) ES2389618T3 (pl)
PL (1) PL2137655T3 (pl)
PT (1) PT2137655E (pl)
RU (1) RU2009141965A (pl)
WO (1) WO2008128227A1 (pl)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
BRPI0716762A2 (pt) 2006-09-13 2013-09-24 Abbott Lab melhorias da cultura celular
TWI610936B (zh) 2008-10-20 2018-01-11 艾伯維有限公司 使用蛋白質ａ親和性層析進行抗體之分離及純化
TW201028433A (en) 2008-10-20 2010-08-01 Abbott Lab Viral inactivation during purification of antibodies
EP2325296A1 (en) * 2009-11-20 2011-05-25 LEK Pharmaceuticals d.d. Production of glycoproteins with low N-glycolylneuraminic acid (Neu5Gc) content
CA2794709A1 (en) * 2010-04-07 2011-10-13 Momenta Pharmaceuticals, Inc. Selection and use of host cells for production of glycoproteins
US9921210B2 (en) 2010-04-07 2018-03-20 Momenta Pharmaceuticals, Inc. High mannose glycans
US9170249B2 (en) 2011-03-12 2015-10-27 Momenta Pharmaceuticals, Inc. N-acetylhexosamine-containing N-glycans in glycoprotein products
EP2511293A1 (en) 2011-04-13 2012-10-17 LEK Pharmaceuticals d.d. A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2013114167A1 (en) * 2012-01-30 2013-08-08 Dr. Reddy's Laboratories Limited Process of obtaining glycoform composition
EP2809773B1 (en) 2012-01-30 2020-09-02 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9505833B2 (en) 2012-04-20 2016-11-29 Abbvie Inc. Human antibodies that bind human TNF-alpha and methods of preparing the same
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013176754A1 (en) 2012-05-24 2013-11-28 Abbvie Inc. Novel purification of antibodies using hydrophobic interaction chromatography
US20150158943A1 (en) * 2012-06-01 2015-06-11 Momenta Pharmaceuticals, Inc. Methods related to adalimumab
WO2013181575A2 (en) * 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to denosumab
EP2856158A4 (en) * 2012-06-01 2016-06-08 Momenta Pharmaceuticals Inc PROCEDURE RELATED TO RITUXIMAB
WO2013181577A2 (en) * 2012-06-01 2013-12-05 Momenta Pharmaceuticals, Inc. Methods related to omalizumab
US20150210753A1 (en) 2012-07-26 2015-07-30 Momenta Pharmaceuticals, Inc. Glycoproteins with anti-inflammatory properties
HK1211981A1 (en) 2012-09-02 2016-06-03 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9677105B2 (en) * 2013-03-14 2017-06-13 Momenta Pharmaceuticals, Inc. Methods of cell culture
US20140271622A1 (en) * 2013-03-14 2014-09-18 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US10450361B2 (en) 2013-03-15 2019-10-22 Momenta Pharmaceuticals, Inc. Methods related to CTLA4-Fc fusion proteins
WO2014179601A2 (en) 2013-05-02 2014-11-06 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
KR20160088331A (ko) * 2013-11-06 2016-07-25 엘앤드제이 바이오사이언스 인코포레이티드 연속적으로 조절되는 중공사 생물반응기
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2015115849A1 (ko) * 2014-01-29 2015-08-06 주식회사 엘지생명과학 배양배지의 최적화를 통한 재조합 단백질의 갈락토오스화를 조절하는 방법
SI3227454T1 (sl) 2014-12-01 2020-06-30 Amgen Inc. Postopek za manipuliranje ravni vsebnosti glikana glikoproteina
CA3001761A1 (en) 2015-10-26 2017-05-04 Lonza Limited A manufacturing facility for the production of biopharmaceuticals
WO2017117218A1 (en) 2015-12-30 2017-07-06 Momenta Pharmaceuticals, Inc. Methods related to biologics
KR102593407B1 (ko) 2016-03-02 2023-10-24 론자 리미티드 개선된 발효 공정
CN118480433A (zh) * 2016-03-10 2024-08-13 隆扎有限公司 可定制的设施
US10689873B2 (en) 2016-03-10 2020-06-23 Lonza Ltd Customizable facility
JP6942736B2 (ja) 2016-06-03 2021-09-29 ロンザ リミテッドＬｏｎｚａ Ｌｉｍｉｔｅｄ 使い捨てバイオリアクター
WO2017212071A1 (en) 2016-06-10 2017-12-14 Lonza Ltd Method for stabilizing proteins
WO2017223269A1 (en) 2016-06-24 2017-12-28 Lonza Ltd. Variable diameter bioreactors
EP3478821A1 (en) 2016-08-02 2019-05-08 Lonza Ltd Customizable facility
US20200054972A1 (en) 2016-11-17 2020-02-20 Andrew Bryce Filter assembly with filter lock design
EP3541490B1 (en) 2016-11-17 2021-03-31 Lonza Limited Filter moving device
US10436338B2 (en) 2016-12-09 2019-10-08 Lonza Ltd Rupture disks for bioreactors and methods of using same
EP3535047A1 (en) 2016-12-09 2019-09-11 Lonza Ltd Method for the reduction of viral titer in pharmaceuticals
EP3555126A1 (en) 2017-01-18 2019-10-23 Lonza Ltd Methods for evaluating monoclonality
US20190360980A1 (en) 2017-02-03 2019-11-28 Lonza Ltd Methods of analyzing pluralities of cells and detecting protein sequence variants in biological product manufacturing
KR102499475B1 (ko) 2017-02-10 2023-02-15 론자 리미티드 세포 배양 시스템 및 방법
CN110494554A (zh) 2017-02-17 2019-11-22 隆扎有限公司 用于生产生物产物变体的方法
JP7467119B2 (ja) 2017-02-17 2024-04-15 ロンザ リミテッド 発現困難タンパク質のための多部位ｓｓｉ細胞
JP7637470B2 (ja) 2017-02-17 2025-02-28 ロンザ リミテッド アデノ随伴ウイルスを生産するための哺乳動物細胞
US10244406B2 (en) 2017-03-07 2019-03-26 Lonza Ltd. Wireless sensor information monitoring
IL270467B2 (en) 2017-06-16 2025-05-01 Lonza Ag A universal self-control platform for a mammalian cell line for the preparation of biological materials
WO2019067966A1 (en) 2017-09-29 2019-04-04 Lonza Ltd. INFUSION APPARATUS FOR USE IN BIOREACTOR SYSTEMS
IL273549B2 (en) 2017-10-06 2023-10-01 Lonza Ag Automated control of cell culture using Raman spectroscopy
IL274776B2 (en) 2017-11-20 2025-02-01 Lonza Ag Process and system for growing cell cultures while preventing lactate accumulation
CN108052801B (zh) * 2017-11-30 2020-06-26 中国科学院计算技术研究所 一种基于正则表达式的n糖结构库构建方法与系统
KR20200093602A (ko) 2017-12-05 2020-08-05 론자 리미티드 트로폴론 분석 방법
US12077786B2 (en) 2018-02-02 2024-09-03 Lonza Ltd Methods of cell selection and modifying cell metabolism
KR20200135781A (ko) 2018-03-26 2020-12-03 암젠 인크 세포 배양에서 생산된 항체의 총 비푸코실화 당형태
US12071607B2 (en) 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
CN112424339B (zh) 2018-07-13 2025-03-28 隆萨有限公司 用于通过降低内源性蛋白质的水平来改善生物产物的生产的方法
WO2020028616A1 (en) 2018-08-02 2020-02-06 Lonza Ltd Methods for manufacturing recombinant protein comprising a disulfide bond
WO2020031115A1 (en) 2018-08-09 2020-02-13 Lonza Ltd. Transfer station for api seed crystals
AR114548A1 (es) * 2018-08-10 2020-09-16 Genentech Inc Estrategias de cultivo celular para modular la glicosilación de proteínas
WO2020041454A1 (en) 2018-08-21 2020-02-27 Lonza Ltd A process for creating reference data for predicting concentrations of quality attributes
CN113227388A (zh) 2018-10-01 2021-08-06 龙沙有限公司 具有可预测和稳定的转基因表达的ssi细胞及形成方法
CN113438953A (zh) 2018-10-11 2021-09-24 动量制药公司 采用高度唾液酸化IgG组合物的治疗
CA3125443A1 (en) 2018-12-31 2020-07-09 Momenta Pharmaceuticals, Inc. Methods of producing ustekinumab
SG11202106852QA (en) 2019-02-11 2021-07-29 Lonza Ag Buffer formulation method and system
EP3931303A1 (en) 2019-12-06 2022-01-05 Regeneron Pharmaceuticals, Inc. Anti-vegf protein compositions and methods for producing the same
US20220389363A1 (en) 2020-01-10 2022-12-08 Lonza Walkersville, Inc. Filter Apparatus and Method for Purifying Biological Processes and Cell Populations
WO2021226444A2 (en) 2020-05-08 2021-11-11 Regeneron Pharmaceuticals, Inc. Vegf traps and mini-traps and methods for treating ocular disorders and cancer
WO2022133105A1 (en) 2020-12-18 2022-06-23 Lonza Biologics Inc. Sterile disconnect for bioprocess systems and method for using same

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4448884A (en) 1982-03-03 1984-05-15 Kms Fusion, Inc. Glass-surface microcarrier for growth of cell cultures
US5135853A (en) 1983-07-22 1992-08-04 Rensselaer Polytechnic Institute Three compartment bioreactor and method of use
US4764471A (en) 1984-01-04 1988-08-16 Nabisco Brands, Inc. Continuous bioreactor and process
US5672502A (en) 1985-06-28 1997-09-30 Celltech Therapeutics Limited Animal cell culture
US5231185A (en) 1985-11-19 1993-07-27 Cornell Research Foundation, Inc. Monosaccharide analog-based glycosidase inhibitors
US5116742A (en) 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US6048729A (en) 1987-05-01 2000-04-11 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
JPH0667317B2 (ja) * 1988-09-21 1994-08-31 財団法人野田産業科学研究所 Ｎ−アセチルヘキソサミンデヒドロゲナーゼ、その製造法及び該酵素を用いるｎ−アセチルグルコサミン又はｎ−アセチルガラクトサミンの定量法及びその定量用キット
US5047335A (en) * 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
DK167813B1 (da) * 1989-12-07 1993-12-20 Carlbiotech Ltd As Pentapeptidderivat, farmaceutisk acceptable salte heraf, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
SK282950B6 (sk) 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
ATE193551T1 (de) 1991-03-18 2000-06-15 Scripps Research Inst Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5733761A (en) 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6063630A (en) 1991-11-05 2000-05-16 Transkaryotic Therapies, Inc. Targeted introduction of DNA into primary or secondary cells and their use for gene therapy
JPH09503905A (ja) * 1993-07-15 1997-04-22 ネオゼ ファーマシューティカルス 糖組成物の合成方法
US5559103A (en) 1993-07-21 1996-09-24 Cytel Corporation Bivalent sialyl X saccharides
TW479061B (en) 1993-12-24 2002-03-11 Mitsubishi Chem Corp Sialic acid derivatives
US5567684A (en) 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
US20030143204A1 (en) 2001-07-27 2003-07-31 Lewis David L. Inhibition of RNA function by delivery of inhibitors to animal cells
WO1998041611A1 (en) 1997-03-20 1998-09-24 Regents Of The University Of Minnesota Process for the continuous culture of cells
US5994511A (en) * 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
WO1999057263A1 (en) 1998-05-07 1999-11-11 Transkaryotic Therapies, Inc. Modifying the expression of the fsh beta gene by homologous recombination
NZ507451A (en) 1998-05-07 2003-12-19 Transkaryotic Therapies Inc Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery and enhancement of g-csf transcription and translation trasfection and infection into mamalian cell
US6949372B2 (en) * 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
DE60032349T2 (de) * 1999-04-26 2007-07-12 Genentech, Inc., South San Francisco Zellenzuchtverfahren für glycoproteine
DE60009956T2 (de) 1999-12-28 2005-04-28 Iso Tis N.V. Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium
US7795002B2 (en) * 2000-06-28 2010-09-14 Glycofi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
AU2001271021A1 (en) * 2000-07-05 2002-01-14 Japan As Represented By Secretary Of Osaka University Process for producing glycoprotein
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US6544788B2 (en) 2001-02-15 2003-04-08 Vijay Singh Disposable perfusion bioreactor for cell culture
WO2002076578A1 (en) * 2001-03-27 2002-10-03 Smithkline Beecham Corporation Control of glycoforms in igg
CA2459040A1 (en) * 2001-09-14 2003-03-27 Mimeon, Inc. Methods of making glycolmolecules with enhanced activities and uses thereof
US20030157108A1 (en) * 2001-10-25 2003-08-21 Genentech, Inc. Glycoprotein compositions
EP1572902B1 (en) 2002-02-01 2014-06-11 Life Technologies Corporation HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
WO2003093430A2 (en) 2002-05-03 2003-11-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for use in preparing sirnas
DE60328214D1 (de) 2002-08-12 2009-08-13 New England Biolabs Inc Verfahren und zusammensetzungen in verbindung mit gen-silencing
EP1467299A3 (en) * 2003-03-28 2005-02-09 Solutia Inc. Methods and structure for automated active pharmaceuticals development
EP1615945B1 (en) * 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
WO2005026720A1 (en) 2003-09-04 2005-03-24 Parivid Llc Methods and apparatus for characterizing polymeric mixtures
US20060127950A1 (en) * 2004-04-15 2006-06-15 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
US8802820B2 (en) * 2004-11-12 2014-08-12 Xencor, Inc. Fc variants with altered binding to FcRn
US20060252672A1 (en) * 2005-04-05 2006-11-09 Betenbaugh Michael J Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation
WO2006109781A1 (ja) * 2005-04-11 2006-10-19 Kyowa Hakko Kogyo Co., Ltd. 糖タンパク質組成物の製造方法
US8759005B2 (en) * 2005-07-11 2014-06-24 Glykos Finland Oy Tissue carbohydrate compositions and analysis thereof
US20070017758A1 (en) * 2005-07-20 2007-01-25 Or Siu W Magnetorheological damper and use thereof
US20090317834A1 (en) * 2006-03-08 2009-12-24 Jarmo Laine Novel cellular glycan compositions
DE202006008733U1 (de) * 2006-05-31 2007-10-11 Dolmar Gmbh Bremsbandhalterung
CA2655246A1 (en) * 2006-06-09 2007-12-21 University Of Maryland, Baltimore Glycosylation engineered antibody therapy
BRPI0716762A2 (pt) * 2006-09-13 2013-09-24 Abbott Lab melhorias da cultura celular
NZ576133A (en) * 2006-10-27 2012-10-26 Abbott Biotech Ltd Crystalline anti-htnfalpha antibodies
GB0624092D0 (en) * 2006-12-01 2007-01-10 Seos Ltd Image display apparatus
EP2097747A1 (en) * 2006-12-22 2009-09-09 Ares Trading S.A. Analytical method for analyzing c-terminus truncation
CA2887752C (en) * 2007-04-03 2020-03-24 Vib Vzw Glycosylation of molecules
AU2008243007A1 (en) * 2007-04-16 2008-10-30 Momenta Pharmaceuticals, Inc. Characterization of N-glycans using exoglycosidases
TW201002346A (en) * 2008-04-11 2010-01-16 Galaxy Biotech Llc Combination of HGF inhibitor and EGF inhibitor to treat cancer
WO2010036443A1 (en) * 2008-09-26 2010-04-01 Eureka Therapeutics, Inc. Cell lines and proteins with variant glycosylation pattern
US11520643B2 (en) * 2008-12-03 2022-12-06 International Business Machines Corporation Clipboard object sharing for instant messaging
JP4892051B2 (ja) * 2009-11-30 2012-03-07 株式会社東芝 電子機器、及び機能設定データ設定方法
US8524217B2 (en) * 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
US8956830B2 (en) * 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9677105B2 (en) * 2013-03-14 2017-06-13 Momenta Pharmaceuticals, Inc. Methods of cell culture

Also Published As

Publication number Publication date
US20100113294A1 (en) 2010-05-06
WO2008128227A1 (en) 2008-10-23
RU2009141965A (ru) 2011-05-27
CN101681396A (zh) 2010-03-24
US20160097074A1 (en) 2016-04-07
EP2137655A1 (en) 2009-12-30
EP2528002A2 (en) 2012-11-28
EP2137655B1 (en) 2012-07-11
BRPI0810471A2 (pt) 2014-11-11
PT2137655E (pt) 2012-09-14
EP2528002B1 (en) 2015-11-04
CA2682738A1 (en) 2008-10-23
JP2010524467A (ja) 2010-07-22
EP2528002A3 (en) 2013-04-03
AU2008240080A1 (en) 2008-10-23
ES2389618T3 (es) 2012-10-29

Similar Documents

Publication Publication Date Title
PL2137655T3 (pl) Zdefiniowane produkty glikoproteinowe i powiązane sposoby
GB0813709D0 (en) Method and product
GB2453308B (en) Composite products
GB0723255D0 (en) Process and product
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
ZA201100373B (en) Cover and related products,and production thereof
EP2193097A4 (en) NANOSTRUCTURE IMPROVED COMPOSITE MATERIALS AND METHOD
GB0815534D0 (en) Process and product
GB0819720D0 (en) Methods and products
GB0809921D0 (en) Product and process therefor
GB0801880D0 (en) Process and product thereof
GB0813687D0 (en) Article and associated method
GB0921001D0 (en) Products and uses
GB0805473D0 (en) Method and article
GB0819883D0 (en) Product and uses
GB0812933D0 (en) Novel products and method
EP2124651A4 (en) PRODUCT AND METHOD FOR DRYING MEAT
GB2455897B (en) Cosmetic products
ZA200902899B (en) Product and process
EP2145245A4 (en) DIGITAL PAPER PRODUCTS AND METHODS CONNECTED THEREWITH
GB0714389D0 (en) Process and product
GB0618706D0 (en) Products
GB0608966D0 (en) Method and product
GB201021694D0 (en) Process and Product Thereof
GB0921525D0 (en) Product and method